Recent Updates — AIMDW

The board of directors approved the second amended and restated bylaws, effective immediately, establishing a classified board structure. Directors are divided into three equal classes with staggered three-year terms expiring at the 2026, 2027, and 2028 annual meetings respectively. The filing also updates corporate governance policies to reflect this change. Ainos operates in the biotechnology sector.

Ainos, Inc. dismissed its independent registered public accounting firm, YCM CPA INC., on July 9, 2026, and simultaneously engaged DLEE Accountancy, Inc. as its new auditor. The company reported no disagreements with YCM regarding accounting principles, financial statement disclosure, or auditing scope, and no reportable events occurred. Ainos, Inc. operates in the healthcare technology sector, focusing on developing advanced AI-driven medical imaging and diagnostics.

On July 3, 2026, Ainos, Inc. entered into a General Agreement for Omnibus Credit Lines with CTBC Bank Co., Ltd. for a short-term unsecured credit facility totaling NT$62,000,000 (approximately US$1,937,800). The facility carries an annual interest rate of 2.5% and matures on September 30, 2026. Ainos, Inc. operates in the healthcare technology industry, providing AI-driven medical diagnostic solutions.